Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units

Conclusion: During nosocomial outbreaks of RSV, administration of palivizumab to all infants in NICU appears to be rational and may help contain outbreaks.
Source: Journal of Tropical Pediatrics - Category: Tropical Medicine Authors: Tags: Original Papers Source Type: research